| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/13/2001 | EP1105150A1 Treatment of tumors with oligonucleotides directed to insulin-like growth factor-i receptor |
| 06/13/2001 | EP1105143A1 Human histone deacetylase gene hd4 |
| 06/13/2001 | EP1104993A1 C3a serum-free clonal cell line and methods of use |
| 06/13/2001 | EP1067968A4 Methods for evaluating a compound for its effect on skin |
| 06/13/2001 | EP0805858B1 Inhibition of neovascularization using vegf-specific oligonucleotides |
| 06/13/2001 | EP0789776B1 Nucleic acid transfer system |
| 06/13/2001 | EP0725798B1 Type i angiotensin ii receptor specific monoclonal antibodies and hybridoma |
| 06/13/2001 | EP0675728B1 Products and methods for improving keratinocyte adhesion to the dermis |
| 06/13/2001 | EP0635040B1 Crosslinked biocompatible encapsulation compositions and methods |
| 06/13/2001 | EP0580649B1 Plant promoter involved in controlling lipid biosynthesis in seeds |
| 06/13/2001 | DE19959582A1 Nukleinsäuren, die für neue Acetylcholinrezeptor-beta-Untereinheiten von Insekten kodieren Nucleic acids coding for new acetylcholine receptor beta subunits of insect |
| 06/13/2001 | DE19956156A1 Verfahren zur Aufbereitung eines Präparates von Thrombozyten und Thrombozytenpräparat Process for the preparation of a preparation of platelets and platelet preparation |
| 06/13/2001 | CN1299416A Lucleic and molecules which code for enzymes derived from wheat and are involved in the synthesis of starch |
| 06/13/2001 | CN1299415A Nucleic acid molecules with code for enzymes derived from wheat and which are involved in the synthesis of starch |
| 06/13/2001 | CN1299414A Compound and method for therapy and diagnosis of lung cancer |
| 06/13/2001 | CN1299411A Hyperthermic inducible expression vectors for gene therapy and methods of use thereof |
| 06/13/2001 | CN1299410A CD 19XCD2 specific polypeptides and uses thereof |
| 06/13/2001 | CN1299409A Immortalised cell lines derived from normal human skin tissues |
| 06/13/2001 | CN1299407A Vascular endothelial growth factor 2 |
| 06/13/2001 | CN1299272A Method and device for modulating the immune response |
| 06/13/2001 | CN1298942A Process for preparing coenzyme Q10 from tobacco |
| 06/12/2001 | US6245974 Matrix attachment regions |
| 06/12/2001 | US6245970 A dna molecule that when introduced into a plant genome modifies the transfer of metabolites in transgenic plants, plasmids, bacteria and yeast |
| 06/12/2001 | US6245969 A polypeptide for producing genetically engineered plants having a phenotype of increased crop yield, enhanced disease resistance and longer-lived vegetative growth phase |
| 06/12/2001 | US6245967 A recombinant dna molecule for the expression of fructose-1,6-bisphosphatase in plant cells resulting to increased photosynthesis rate |
| 06/12/2001 | US6245964 A non-human animal that is homozygous for the diploid genome encoding a polypetide with a swedish mutation at position 595 with amino acid residues being aspargine and leucine; this mutation is detectable in brain homogenate |
| 06/12/2001 | US6245896 A polypeptide; diagnosis and therapy of endometriosis, antitumor/antiproliferative/anticarcinogenic agents; enhancing in situ fertilization |
| 06/12/2001 | US6245888 Proteins involved in the regulation of cell—cell adhesion and uses thereof |
| 06/12/2001 | US6245887 An isolated enzyme; for producing large quantities of c-terminal .alpha.-amidating enzyne |
| 06/12/2001 | US6245750 Thymidine phosphoramide derivative; antiproliferative, anticarcinogenic agents; enzyme inhibitors; |
| 06/12/2001 | US6245737 Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins |
| 06/12/2001 | US6245567 Activating egg extracts and method of preparation |
| 06/12/2001 | US6245566 Human embryonic germ cell line and methods of use |
| 06/12/2001 | US6245565 Recombinase Mediated DNA modifications |
| 06/12/2001 | US6245564 Identifying single mammalian neural cell type or progenitor by fluorescent protein expression; fluorescence activated cell sorting; used for engraftment and transplantation, growth control and functional integration |
| 06/12/2001 | US6245563 Enhanced activation of natural killer cells using an NK cell activator and hydrogen peroxide scavenger or inhibitor |
| 06/12/2001 | US6245562 Determining chromosomal breakpoint gene other than the immunoglobulin gene which is located in chromosome 14; complex between probe and the mrna; multiple myeloma |
| 06/12/2001 | US6245561 For inducement of cell differentiation, and enhancement of cell phenotypic expression, vitality, longevity, and production; differentiation of precursor cells into specialized cells; autoimmune diseases |
| 06/12/2001 | US6245545 Culturing a cell transformed with the vector comprising the isolated dna encoding the endonuclease of staphloccus warneri; used to cleave dna molecules into fragments for molecular cloning and gene characterization |
| 06/12/2001 | US6245544 An isolated polypeptide having a specific amino acid sequence; antiproliferative, anticarcinogenic, antitumor, antiarthritic, antiinflammatory agents; metastatsis; psoriasis; vision defects |
| 06/12/2001 | US6245540 Human choline acetyltransferase |
| 06/12/2001 | US6245537 Removing endotoxin with an oxdizing agent from polyhydroxyalkanoates produced by fermentation |
| 06/12/2001 | US6245526 Mammalian nucleotide sequences which code polypeptides for the classification, diagnosis, treatment, and prevention of cell proliferative and lipid defects |
| 06/12/2001 | US6245523 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 06/12/2001 | US6245510 Isolating preferential plant nucleotide sequences; incubate plant nucleotide sequences with probe, isolate hybridization products |
| 06/12/2001 | US6245503 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| 06/12/2001 | US6245333 Isolated protein processed to peptides which form complexes with HLA molecules |
| 06/12/2001 | US6245330 Recombinant adenoviruses coding for glial-derived neurotrophic factor (GDNF) |
| 06/12/2001 | CA2173595C Dna encoding prostaglandin receptor ip |
| 06/12/2001 | CA2050058C Recombinant mite allergen |
| 06/07/2001 | WO2001040798A2 Methods of using randomized libraries of zinc finger proteins for the identification of gene function |
| 06/07/2001 | WO2001040518A1 Targeted methods of drug screening using co-culture methods |
| 06/07/2001 | WO2001040491A2 Udp-glucose:aglycon-glucosyltransferase |
| 06/07/2001 | WO2001040489A1 Methods for producing a polypeptide using a consensus translational initiator sequence |
| 06/07/2001 | WO2001040478A2 Isolated polynucleotides having a reduced or an increased content of epigenetic control motifs and uses thereof |
| 06/07/2001 | WO2001040477A1 Transposase and method of gene modification |
| 06/07/2001 | WO2001040474A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/07/2001 | WO2001040473A2 Pseudomonas aeruginosa antigens |
| 06/07/2001 | WO2001040472A2 Streptococcus pneumoniae antigens |
| 06/07/2001 | WO2001040471A1 Antigenic protein lppq of mycoplasma mycoidessubsp.(mycoides)sc., its preparation and use |
| 06/07/2001 | WO2001040467A1 Human cytokine receptor |
| 06/07/2001 | WO2001040457A1 Semaphorin receptor |
| 06/07/2001 | WO2001040456A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040454A1 Method and apparatus for selectively targeting specific cells within a cell population |
| 06/07/2001 | WO2001040446A1 Pour-on formulations |
| 06/07/2001 | WO2001040445A1 Cell isolation method |
| 06/07/2001 | WO2001040444A2 Method and compositions for producing cell transplants |
| 06/07/2001 | WO2001040443A2 Method for producing adherent animal cells |
| 06/07/2001 | WO2001040440A2 Maize mip synthase promoter |
| 06/07/2001 | WO2001040309A2 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 06/07/2001 | WO2001040307A1 Antibodies against signal regulator proteins |
| 06/07/2001 | WO2001040305A1 Novel abcb9 transporter and uses thereof |
| 06/07/2001 | WO2001040303A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | WO2001040279A2 Hbv sequences |
| 06/07/2001 | WO2001040276A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 06/07/2001 | WO2001040271A2 Cancer associated antigens and uses therefor |
| 06/07/2001 | WO2001040257A2 Modified il-12 subunits and nucleic acids encoding them |
| 06/07/2001 | WO2001040251A1 Transforming growth factor alpha hiii |
| 06/07/2001 | WO2001040249A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001039784A1 Pancreatic stem cells and their use in transplantation |
| 06/07/2001 | WO2001039600A1 Use of hsp27 as an anti-inflammatory agent |
| 06/07/2001 | WO2001032865A8 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 06/07/2001 | WO2001011071A3 Bioproduction of para-hydroxycinnamic acid |
| 06/07/2001 | WO2001011064A3 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy |
| 06/07/2001 | WO2001010902A3 Nucleoc acids and secreted polypeptides encoded thereby |
| 06/07/2001 | WO2001007612A3 Receptors and associated proteins |
| 06/07/2001 | WO2000032752A9 Psca: prostate stem cell antigen and uses thereof |
| 06/07/2001 | US20010002992 Imaging means comprising an imaging agent attached to an agent that binds to a cell surface element of a mononuclear phagocyte; therapy of cancer or coronary heart disease |
| 06/07/2001 | DE19957763A1 Vessel-like particles containing encapsulated cells, useful e.g. as substitute for feeder cells in animal cell cultures, provide material exchange with their surroundings |
| 06/07/2001 | DE19955576A1 Transferverbindungen, ihre Herstellung und ihre Verwendung Transfer compounds, their preparation and their use |
| 06/07/2001 | DE19955558A1 Permanente Amniozyten-Zelllinie, ihre Herstellung und Verwendung zur Herstellung von Gentransfervektoren Permanent amniocytic cell line, their preparation and use for producing gene transfer vectors |
| 06/07/2001 | CA2822851A1 Improved flow cytometer nozzle and flow cytometer sample handling methods |
| 06/07/2001 | CA2739572A1 Improved flow cytometer nozzle and flow cytometer sample handling methods |
| 06/07/2001 | CA2709291A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2394996A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | CA2394142A1 Isolated polynucleotides having a reduced or an increased content of epigenetic control motifs and uses thereof |
| 06/07/2001 | CA2393369A1 Human cytokine receptor |
| 06/07/2001 | CA2393360A1 Targeted methods of drug screening using co-culture methods |
| 06/07/2001 | CA2392991A1 Semaphorin receptor |
| 06/07/2001 | CA2392946A1 Novel abcb9 transporter and uses thereof |